Colesevelam HCl: a non-systemic lipidaltering drug

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.5, 2003-05, pp. : 779-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Systemic Drugs: A Critical Review

Current Pharmaceutical Design, Vol. 18, Iss. 10, 2012-04 ,pp. : 1434-1445

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Colesevelam HCl on Single-Dose Fenofibrate Pharmacokinetics

By Michael R. Jones

Clinical Pharmacokinetics, Vol. 43, Iss. 13, 2004-01 ,pp. : 943-950

Adis International

Access to resources Recommend Favorite

Colesevelam

By Melian E.B. Plosker G.L.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 141-146

Adis International

Access to resources Recommend Favorite

Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study

By Tamilvanan Shunmugaperumal Abdulrazik Muhammad Benita Simon

Journal of Drug Targeting, Vol. 14, Iss. 10, 2006-12 ,pp. : 670-679

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment with Colesevelam HCl and Pravastatin in a Patient Previously Hospitalised with Severe Normal CPK Myopathy on Introduction of Simvastatin

By Moore John D.

Clinical Drug Investigation, Vol. 25, Iss. 6, 2005-01 ,pp. : 417-420

Adis International

Access to resources Recommend Favorite